Company news
Simulations Plus, Inc. (NASDAQ:SLP) news
Every Simulations Plus, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 2
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
June 12, 2024
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
May 15, 2024
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
April 3, 2024
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
March 20, 2024
Simulations Plus Launches Corporate Development Initiative
February 13, 2024
Simulations Plus Releases GastroPlus® Version 9.9
January 30, 2024
Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant
January 9, 2024
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results
January 3, 2024
Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth
January 3, 2024
Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date
December 20, 2023
Simulations Plus Outlines Paths to Win at 2023 Investor Day
November 14, 2023
Simulations Plus to Host Investor Day on Tuesday, November 14th
October 31, 2023
Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
October 25, 2023
Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
October 11, 2023
Simulations Plus Receives New FDA Grant Award
September 21, 2023
Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)
August 24, 2023
Simulations Plus Releases ADMET Predictor® 11
July 13, 2023
Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
July 6, 2023
Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date
June 21, 2023
Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
June 20, 2023
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
May 10, 2023
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
April 18, 2023
Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
April 5, 2023
Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
March 28, 2023
Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
March 21, 2023
Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
March 15, 2023
Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
February 9, 2023
Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
January 12, 2023
Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
January 11, 2023
Simulations Plus Reports First Quarter Fiscal 2023 Financial Results
January 4, 2023
Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call
December 19, 2022
Simulations Plus and the University of Bath Awarded New FDA Grant
November 15, 2022
Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code
November 3, 2022
Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results
October 26, 2022
Simulations Plus Announces Cash Dividend
October 20, 2022
Simulations Plus Releases GastroPlus® Version 9.8.3
October 12, 2022
Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call
October 11, 2022
Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
August 31, 2022
Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)
August 4, 2022
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
July 21, 2022
Simulations Plus Realizes Early Success with its Concierge Program
July 14, 2022
Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
July 6, 2022
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
June 21, 2022
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
May 26, 2022
Simulations Plus Successfully Delivers FDA-Funded Project
April 28, 2022
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
April 21, 2022
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
April 6, 2022
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
March 29, 2022
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
March 22, 2022
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders
March 17, 2022